[{"AccountsPayableCurrent_0_Q3_USD":8557000.0,"OtherLiabilitiesCurrent_0_Q3_USD":678000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":233428000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":331000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":143000.0,"OperatingLeaseExpense_3_Q3_USD":237000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":173000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":187008000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":185046.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q3_shares":4018547.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":719000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":1261000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":314000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":7708000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":317000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":21000.0,"ShareBasedCompensation_3_Q3_USD":8000000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":46595000.0,"OtherAssetsNoncurrent_0_Q3_USD":86000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":16317000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":1986000.0,"AccruedInsuranceCurrent_0_Q3_USD":468000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":null,"PaymentsOfStockIssuanceCosts_1_Q3_USD":12991000.0,"PaymentsForRepurchaseOfEquity_3_Q3_USD":9024000.0,"OtherInterestAndDividendIncome_1_Q3_USD":20000.0,"OtherInterestAndDividendIncome_3_Q3_USD":140000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1586000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1467000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":210000.0,"AccruedIncomeTaxes_0_Q3_USD":0.0,"OperatingLeaseLiability_0_Q3_USD":1677000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":52000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":363000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":372000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":381000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":456000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1938000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":201002000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5268000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":261000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":247126000.0,"LiabilitiesCurrent_0_Q3_USD":16344000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":238749000.0,"Liabilities_0_Q3_USD":17811000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":846000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":14605000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8451000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.94,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-46000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.07,"CommonStockValue_0_Q3_USD":24000.0,"CommonStockSharesOutstanding_0_Q3_shares":24354882.0,"CommonStockSharesIssued_0_Q3_shares":24354882.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":233428000.0,"AssetsCurrent_0_Q3_USD":236133000.0,"Assets_0_Q3_USD":238749000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3833501.0,"AdditionalPaidInCapital_0_Q3_USD":338685000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":208000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-46078000.0,"NetIncomeLoss_1_Q3_USD":-24753000.0,"NetIncomeLoss_3_Q3_USD":-61083000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"OperatingIncomeLoss_3_Q3_USD":-61200000.0,"OperatingIncomeLoss_1_Q3_USD":-24768000.0,"OperatingExpenses_3_Q3_USD":61200000.0,"OperatingExpenses_1_Q3_USD":24768000.0,"InterestPaidNet_3_Q3_USD":23000.0,"InterestExpense_3_Q3_USD":23000.0,"InterestExpense_1_Q3_USD":5000.0,"CommonStockSharesAuthorized_0_Q3_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"AccruedLiabilitiesCurrent_0_Q3_USD":6901000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":20779465.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":23050256.0,"StockholdersEquity_0_Q3_USD":220938000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-117771000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":944000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":255819000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2705000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":46000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":null,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":606000.0,"Ticker":"BTAI","CIK":"1720893","name":"BIOXCEL THERAPEUTICS, INC.","OfficialName":"BioXcel Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"417746551.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]